Related Experiment Video
Updated: May 21, 2026
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Expression of BMI1 and p16 in laryngeal squamous cell carcinoma
Eugenia Allegra1, Rosario Caltabiano, Andrea Amorosi
1Department of Otolaryngology-Head and Neck Surgery, University Magna Graecia of Catanzaro, Italy. eualle@unicz.it
Background:
The clinical evolution of laryngeal squamous cell carcinoma (SCC) is undetectable with the current staging criteria. To more completely understand the biology of laryngeal SCC, we assessed the expression of the proteins B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) and p16.
Methods:
We assessed immunohistochemically the expression of BMI1 and p16 in 25 laryngeal SCCs at different stages.
Results:
High BMI1 expression was detected in 11.7% of glottic tumors and in 50% of supraglottic tumors. No significant differences were observed in the patients' clinical data after they were stratified by the tumor expression of p16. The expression of nuclear BMI1 in the absence of p16 immunoreactivity correlated significantly with the pN status of the primary tumors.
Conclusion:
Nuclear BMI1 expression in the absence of p16 expression seems to characterize a subset of patients with a high risk of developing lymph node metastasis.
Related Concept Videos
02:23Abnormal Proliferation
02:39lncRNA - Long Non-coding RNAs
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...